Ureteroscopy with Laser Lithotripsy for Kidney Stones

Ureteroscopy with laser lithotripsy is a minimally invasive surgical procedure in which a thin, flexible or semi-rigid scope is passed through the urethra and bladder into the ureter or kidney, and a laser fiber is used to break apart kidney or ureteral stones. It is one of the most commonly performed stone surgeries worldwide, with stone-free rates typically ranging from about 75% to over 90% depending on stone size and location. The procedure avoids any external incisions, and most people go home the same day, but the recovery experience varies considerably depending on whether a temporary internal stent is left behind.

What Happens During the Procedure

You are placed under general anesthesia or, in some settings, sedation. The surgeon threads a ureteroscope, a slender instrument roughly the diameter of a pencil, up through the natural urinary tract. Semi-rigid scopes work well for stones sitting in the ureter itself, while flexible scopes can navigate the sharper angles needed to reach stones inside the kidney. Once the scope reaches the stone, a laser fiber thinner than a strand of spaghetti is advanced through the scope’s working channel and positioned against the stone’s surface.

The laser delivers rapid pulses of energy that vaporize or fracture the stone. Fragments small enough to pass on their own are left in place; larger pieces are plucked out with tiny wire baskets. In many cases the surgeon also places a ureteral access sheath, a thin tube that sits in the ureter and acts as a highway for the scope to slide in and out. Access sheaths help keep pressure inside the kidney lower and speed up fragment retrieval, though they carry a small risk of ureteral scraping or injury during insertion.¹

A study comparing sedation to general anesthesia for ureteroscopy found comparable complication rates between the two approaches, suggesting sedation can be a reasonable option for selected patients.² Your anesthesia choice is usually a conversation between you, the surgeon, and the anesthesiologist, influenced by stone complexity and your overall health.

Success Rates and What “Stone-Free” Really Means

Quoted success rates for ureteroscopy can be confusing because “stone-free” does not always mean the same thing. If “stone-free” is defined strictly as zero visible fragments on a CT scan afterward, the rate in one large real-world study of over 450 patients was about 43%. When tiny residual fragments under 3 or 4 millimeters were counted as a success, that figure climbed to roughly 58% and 79%, respectively.³ Another study found an overall stone-free rate of about 54% by the strict no-fragments definition and roughly 75% by a practical definition allowing small residuals.⁴

That gap matters. Tiny leftover fragments often pass without any trouble, and many surgeons consider them clinically insignificant. But they can occasionally grow into new stones over time, so understanding which definition your surgeon is using when they quote you a success rate is worth asking about.

Stone size makes a significant difference. For stones in the 2 to 3 centimeter range, a systematic review of flexible ureteroscopy with laser lithotripsy reported stone-free rates around 96%. For stones larger than 3 centimeters, the rate dropped to about 85%, and the risk of serious complications rose.⁵ Very large stones are often better served by a different approach.

How It Compares to Shock Wave Lithotripsy

Shock wave lithotripsy, or SWL, is the main non-invasive alternative. It uses focused sound waves delivered from outside the body to shatter stones. For small ureteral stones under about a centimeter, both procedures achieve good clearance rates in the range of 86% to 90%.⁶ Where ureteroscopy pulls ahead is with larger or harder-to-reach stones. A study looking at lower pole kidney stones between 10 and 20 millimeters found ureteroscopy cleared about 87% of stones versus roughly 68% for SWL, and the retreatment rate for SWL was dramatically higher at 60% compared to 8%.⁷

For smaller lower pole stones of 10 millimeters or less, a recent randomized trial found complete clearance was about twice as likely with ureteroscopy (72%) compared to SWL (36%).⁸ That disparity is partly because the lower pole of the kidney is a cul-de-sac where gravity works against fragment passage after SWL. Ureteroscopy can physically reach in and extract those fragments, which gives it an edge in that specific location.

SWL’s advantages are that it involves no anesthesia or only light sedation, requires no scope insertion, and costs less in terms of immediate procedure fees. But those savings can evaporate when the retreatment rate is factored in.⁹

When Percutaneous Nephrolithotomy Wins Out

For stones in the 1 to 2 centimeter range, particularly those in the lower pole of the kidney, the choice between ureteroscopy and mini-percutaneous nephrolithotomy (mini-PCNL) is a genuine trade-off. Mini-PCNL involves making a small puncture through the back into the kidney and using a scope through that channel, which gives the surgeon a wider working pathway and more direct access to stone fragments.

A randomized trial comparing the two for 1 to 2 centimeter stones found that mini-PCNL had a substantially higher stone-free rate (76% vs 46% using a strict 2-millimeter cutoff), though ureteroscopy required far less radiation exposure during the procedure.¹⁰ Another trial specific to lower pole stones of the same size confirmed the clearance advantage for mini-PCNL, at roughly 72% versus 37% for ureteroscopy when every last fragment was counted.¹¹ When fragments up to 4 millimeters were allowed, the gap narrowed to 86% versus 66%.

Neither trial showed a meaningful difference in complication rates. So the trade-off is straightforward: mini-PCNL clears stones more completely but involves a puncture through the flank, slightly longer operating times, and occasionally a longer recovery. For people who want to avoid any incision at all and are willing to accept a higher chance of small residual fragments, ureteroscopy remains a reasonable choice.

Holmium Versus Thulium Fiber Lasers

For roughly two decades, the holmium:YAG laser was the only real option for ureteroscopic stone surgery. It remains the most widely used laser worldwide. More recently, thulium fiber lasers have entered the picture, and the early evidence suggests they hold a few practical advantages.

A meta-analysis comparing the two found that thulium fiber lasers achieved a higher stone-free rate, shorter operating times, and significantly less stone retropulsion, the annoying phenomenon where a pulse of laser energy sends a fragment bouncing away from the scope’s line of sight.¹² Complication rates between the two lasers were comparable. An in-vitro bench study found the thulium fiber laser ablated stone material about 27% faster per minute and used about 24% less energy per milligram of stone destroyed, with no urothelial damage detected for either laser in an animal model.¹³

A single-center prospective study comparing the two lasers during semi-rigid ureteroscopy showed similar total operative times and hospital stays, but noted better visibility for the surgeon and less stone retropulsion with the thulium fiber laser.¹⁴ The thulium fiber laser is still newer and less widely available, so most people undergoing the procedure today will still encounter a holmium laser, which works well and has a long safety record.

Dusting Versus Fragmentation

Surgeons use two broad laser strategies. “Dusting” means running the laser at high frequency and low energy to turn the stone into fine powder that washes out naturally with urine. “Fragmentation” means cracking the stone into discrete chunks and actively removing them with a basket. A meta-analysis comparing the two strategies found no significant difference in overall stone-free rates, complication rates, operative time, or hospital stay.¹⁵

A prospective randomized study of large proximal ureteral stones reported a slightly higher stone-free rate with dusting (about 97%) compared to fragmentation (about 87%), though the dusting group had modestly longer operative times.¹⁶ In practice, many surgeons use a hybrid approach, fragmenting the stone into a few manageable pieces and then dusting whatever remains. The choice often comes down to surgeon preference, stone composition, and how the stone responds to the first few pulses of laser energy.

Complications and Safety

Ureteroscopy with laser lithotripsy is considered safe, but it is not complication-free. A large Japanese multicenter survey reported an overall complication rate of about 10.5%. The most common issue was postoperative fever above 38°C, occurring in roughly 7% of cases. Septic shock was rare at under 1%, and postoperative death was exceedingly uncommon at 0.04%. Ureteral perforation happened in about 1.4% of procedures, while ureteral avulsion, a more serious injury, occurred in only 0.03%.¹⁷

Ureteral stricture, a late narrowing of the ureter from scar tissue, developed in about 0.8% of cases in that same survey. A prospective study tracking stricture rates found a similar figure of 1.5%, with impacted stones and the use of larger-caliber scopes as potential contributing factors.¹⁸ Stray laser pulses that miss the stone can also injure the ureteral lining, which is one mechanism by which strictures may form.¹⁹

Infection is the complication people feel most acutely. One study found that about 10% of patients developed urosepsis after flexible ureteroscopy, with a history of urinary tract infections being the strongest predictor.²⁰ If you have a history of recurrent urinary infections, your surgeon will likely prescribe prophylactic antibiotics and may obtain a urine culture before scheduling the procedure.

The Stent Debate

After most ureteroscopies, surgeons place a ureteral stent, a soft plastic tube that curls at both ends, bridging the kidney and bladder to keep urine flowing while the ureter heals. Stents are typically removed within a week or two, either by pulling on a string left dangling from the urethra or during a brief office procedure with a small scope.

Stents are one of the most complained-about parts of the entire experience. A meta-analysis found that stented patients had roughly double the rate of urinary urgency, frequency, and burning compared to unstented patients, with no improvement in stone-free rates, infection rates, or long-term stricture risk.²¹ A randomized trial of uncomplicated distal ureteral stone removal found that patients without stents had significantly less pain, fewer urinary symptoms, and used fewer pain medications, though about 7% of unstented patients needed hospital readmission for flank pain.²²

The upshot is that stenting is not always necessary after an uncomplicated procedure, particularly for small ureteral stones.²³ But for procedures involving larger stones, significant ureteral manipulation, or any concern about swelling, most surgeons still place one. Ask your surgeon beforehand about their stent policy and what factors would tip the decision either way.

Managing Stent Symptoms

If you do get a stent, there are ways to take the edge off. Alpha-blocker medications, the same class of drugs used for enlarged prostate symptoms, can help. A meta-analysis found that alpha-blockers significantly reduced stent-related pain, particularly during the first few weeks after placement.²⁴ Another meta-analysis comparing alpha-blockers to antimuscarinic drugs, a different class sometimes prescribed for bladder spasms, found no significant difference between the two for stent-related urinary symptoms or quality of life.²⁵ Many surgeons now routinely prescribe an alpha-blocker alongside standard pain medications for anyone going home with a stent.

Practical tips that patients consistently report helping: stay well hydrated, avoid heavy lifting or vigorous exercise while the stent is in place, and use over-the-counter anti-inflammatory medications as directed. Some people find that certain positions, particularly lying on the stented side, trigger more discomfort, so experimenting with sleep positions can make a difference.

Preoperative Stenting

Separate from the post-procedure stent, some surgeons place a stent days or weeks before the main surgery to passively dilate the ureter and make scope passage easier. A meta-analysis found that pre-stented patients had modestly higher stone-free rates, particularly when flexible ureteroscopy was planned.²⁶ However, a separate study found that while pre-stenting shortened operative time and improved the immediate day-after stone-free rate, the one-month stone-free rate and complication rate were not significantly different, leading the authors to conclude that routine pre-stenting is not warranted.²⁷ In practice, pre-stenting is most useful when a surgeon attempts the scope and finds the ureter too tight to pass safely, necessitating a staged approach.

Recovery and Getting Back to Normal

Most people go home the same day. If there is no stent, recovery is often surprisingly quick, with many patients returning to desk work within a couple of days. With a stent in place, the recovery experience tends to be bumpier. Daily symptom surveys from one study showed that pain intensity, pain interference with daily activities, and urinary bother all peaked in the first few days after the procedure and then gradually improved, with most measures trending back toward baseline by the time the stent was removed.²⁸

Longer-term quality-of-life data is reassuring. A study tracking multiple dimensions of well-being found that patients were generally back to their pre-surgical baseline by the one-month mark, with physical function, fatigue, sleep, and social participation all returning to normal ranges.²⁹ Pain interference, the degree to which discomfort limits what you can do, tends to be the slowest dimension to resolve, but even that typically normalizes within a few weeks.

Ureteroscopy in Pregnancy and Children

Kidney stones during pregnancy present a particular challenge because most standard imaging and treatments carry risks to the developing baby. Ureteroscopy with holmium laser lithotripsy has been used safely in pregnant patients, with one study reporting complete stone fragmentation in all 15 cases and no urological or obstetric complications.³⁰ Shock wave lithotripsy is absolutely contraindicated in pregnancy, and percutaneous surgery carries higher risks, making ureteroscopy the go-to interventional option when a pregnant patient cannot pass a stone on her own.

In children, the procedure is also feasible but requires downsized instruments and careful imaging guidance. A feasibility study demonstrated that ultrasound-guided ureteroscopy, which avoids radiation exposure entirely, could be safely performed in pediatric patients.³¹ Even for larger stones of 2 centimeters or more in children, one referral center reported a first-procedure stone-free rate of over 91% with holmium laser and only a single minor complication (postoperative fever) across the entire series.³²

Single-Use Versus Reusable Scopes

Flexible ureteroscopes are delicate instruments that break. Historically, hospitals purchased reusable scopes, sent them for sterilization after each case, and paid for frequent and expensive repairs. Single-use disposable scopes, introduced in the last decade, sidestep sterilization entirely and guarantee a pristine instrument for every patient. An in-vitro comparison found that single-use scopes generally had better deflection ability and slightly superior irrigation flow compared to their reusable counterparts, though reusable scopes provided better image quality.³³

The cost picture is not as straightforward as you might expect. A systematic review found that per-procedure costs for reusable and single-use scopes overlap considerably in high-volume centers, landing in a range of roughly $1,200 to $1,750 for reusable and $1,300 to $3,200 for single-use.³⁴ One cost analysis from a secondary hospital, where procedure volume is lower and reusable scope repair costs add up faster, found that single-use scopes were actually cheaper per case.³⁵ For you as a patient, the scope type rarely changes the out-of-pocket cost, but it is one of many behind-the-scenes factors hospitals weigh when setting up a stone surgery program.

Preventing the Next Stone

Getting a stone removed does not address why the stone formed. Roughly half of first-time stone formers will develop another stone within ten years if they change nothing about their habits. The standard prevention workup involves a 24-hour urine collection, where you save all your urine for a full day so a lab can measure the concentrations of stone-forming substances like calcium, oxalate, uric acid, and citrate. Guidelines recommend this test for recurrent stone formers and interested first-time patients, though the evidence that it accurately predicts who will recur or how well treatment will work remains limited.³⁶

What the test does well is guide specific dietary and medication changes: reducing sodium if your urine sodium is high, increasing citrate intake if citrate is low, starting a thiazide diuretic if urine calcium is persistently elevated. These tailored interventions are more effective than generic advice to “just drink more water,” though generous fluid intake, enough to produce over two liters of urine per day, remains the single most impactful habit change for everyone. If your surgeon sends the stone fragments for chemical analysis after your procedure, that composition data further refines the prevention strategy. A calcium oxalate stone calls for a different dietary approach than a uric acid stone, and knowing which type you form makes prevention considerably more targeted.